切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2022, Vol. 16 ›› Issue (04) : 443 -446. doi: 10.3877/cma.j.issn.1674-3946.2022.04.025

论著

cT1N0期甲状腺癌三种腔镜术式和开放术式的对比研究
闵逸洋1, 赵宁2,(), 王沛豪1   
  1. 1. 100069 北京,首都医科大学
    2. 100050 北京,首都医科大学附属北京友谊医院普通外科分中心,国家消化系统疾病临床医学研究中心
  • 收稿日期:2021-11-07 出版日期:2022-07-14
  • 通信作者: 赵宁

Comparative study of three endoscopic and open methods for cT1N0 thyroid cancer

Yiyang Min1, Ning Zhao2,(), Peihao Wang1   

  1. 1. Capital Medical University,Beijing 100069,China
    2. The General Surgery Branch of Beijing Friendship Hospital,Capital Medical University,National Research Center for Clinical Medicine of Digestive Diseases,Beijing 100050,China
  • Received:2021-11-07 Published:2022-07-14
  • Corresponding author: Ning Zhao
  • Supported by:
    Undergraduate Research and Innovation Project of Capital Medical University(XSKY2021208)
引用本文:

闵逸洋, 赵宁, 王沛豪. cT1N0期甲状腺癌三种腔镜术式和开放术式的对比研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(04): 443-446.

Yiyang Min, Ning Zhao, Peihao Wang. Comparative study of three endoscopic and open methods for cT1N0 thyroid cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(04): 443-446.

目的

评估甲状腺乳头状癌(PTC)三种腔镜术式和开放术式的治疗效果。

方法

回顾性分析2019年10月至2021年10月109例女性cT1N0期PTC手术治疗患者的临床资料,根据不同术式分为四个组,包括开放组(n=34例),乳晕组(n=34例),口腔组(n=26例)和腋窝组(n=14例)。采用SPSS 26.0统计软件分析数据,不同术式围手术期各项指标等计量资料以(

xˉ
±s)表示,组间比较采用单因素方差分析;术后并发症用[n(%)]表示,采用χ2检验或Fisher精确检验。P<0.05为差异有统计学意义。

结果

三组腔镜手术中口腔入路组患者手术时间最长(t=151.1 min),腋窝入路时间次之(t=125.4 min),乳晕入路最短(t=99.9 min),但三组均比开放组(t=75.6 min)手术时间长(P<0.001);腔镜手术组患者的淋巴结转移数量和每日引流量与开放组相比均没有明显区别(P>0.05),但是腋窝组患者淋巴结清扫数量(n=4.1)不仅少于口腔组(n=7.7,P=0.004)和乳晕组(n=6.9,P=0.034),甚至少于开放组(n=6.7,P=0.030);开放组并发症发生率为2.9%,腔镜口腔组为3.8%,其余两组均无术后并发症发生,四组患者术后并发症发生率差异无统计学意义(P>0.05)。

结论

腔镜手术治疗cT1N0期甲状腺癌的效果与开放手术相同。腔镜手术不同术式中,腋窝入路的甲状腺手术治疗效果仍然有一定的局限性。

Objective

To evaluate the effects of three endoscopic and open treatments for papillary thyroid carcinoma(PTC).

Methods

The clinical data of 109 female patients undergoing cT1N0 PTC surgery from October 2019 to October 2021 were retrospectively analyzed. They were divided into four groups according to different surgical methods,open group(n=34 cases),areola group(n=34 cases),oral group(n=26 cases)and axillary group(n=14 cases). SPSS 26.0 statistical software was used. The perioperative indicators of different surgical procedures were expressed as(

xˉ
±s). One-way ANOVA was used for comparison between groups. Postoperative complications were expressed by χ2 test,P<0.05 was considered statistically significant.

Results

Among the three groups,the oral approach group had the longest operation time(t=151.1 min),followed by the axillary group(t=125.4 min),and the areola approach(t=99.9 min),but he three groups had longer operation time than the open group(t=75.6 min)(P<0.001);There was no significant difference in the number of lymph node metastasis and daily drainage between the endoscopic surgery group and the open group(P>0.05),but the number of lymph node dissection in the axillary group(n=4.1)was not only lower than that in the oral group(n=7.7,P=0.004)and the areola group(n=6.9,P=0.034). Even less than the open group(n=6.7,P=0.030);The incidence of complications was 2.9% in the open group and 3.8% in the endoscopic oral group. No postoperative complications occurred in the other two groups,and there was no significant difference in the incidence of postoperative complications among the four groups(P>0.05).

Conclusion

Endoscopic surgery for cT1N0 thyroid cancer has the same effect as open surgery. In endoscopic surgery,the effect of axillary approach for thyroid surgery is still limited.

表1 109例cT1N0期PTC不同术式四组患者一般资料对比[(
xˉ
±s),例]
表2 109例cT1N0期PTC不同术式四组患者围手术期相关指标对比(
xˉ
±s)
表3 109例cT1N0期PTC不同术式四组患者术后并发症比较[例(%)]
[1]
Jongekkasit IJitpratoom PSasanakietkul T,et al. Transoral Endoscopic Thyroidectomy for Thyroid Cancer[J]. Endocrinol Metab Clin North Am201948(1):165-180.
[2]
李宝元,郭雅文. 腔镜甲状腺手术研究的进展[J]. 腹腔镜外科杂志202025(4):312-315.
[3]
李涛,焦良和,朱正才,等.三种手术方式治疗 cT1N0 期甲状腺癌的近期疗效及安全性比较[J/CD].中华普外科手术学杂志(电子版)202014(6):624-627.
[4]
李红强,樊玉霞,陈亚丽,等. 单侧甲状腺微小乳头状癌腔镜手术中3种入路的临床评价[J]. 郑州大学学报(医学版)202156(2):160-163.
[5]
陈立波,丁勇,关海霞,等. 中国临床肿瘤协会(CSCO)持续/复发及转移性分化型甲状腺癌诊疗指南-2019[J]. 肿瘤的预防和治疗201932(12):1051-1080.
[6]
Vaisman FTuttle RM. Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer[J]. Endocrinol Metab Clin North Am201948(1):99-108.
[7]
Jongekkasit IJitpratoom PSa sanakietkul T,et al. Transoral Endoscopic Thyroidectomy for Thyroid Cancer[J]. Endocrinol Metab Clin North Am201948(1):165-180.
[8]
康鸿斌,李江涛,李鑫,等. 三种术式治疗甲状腺癌的疗效比较[J/CD]. 中华普外科手术学杂志(电子版)201913(2):186-189.
[9]
Shen SHu XQu R,et al. Comparing quality of life between patients undergoing trans-areola endoscopic thyroid surgery and trans-oral endoscopic thyroid surgery[J]. BMC Surgery202121(1):277.
[10]
张超,陈剑平. 口腔前庭及经乳晕入路切口腔镜甲状腺切除术治疗甲状腺结节的疗效对比研究[J/CD]. 中国内镜杂志(电子版)202112(5):54-60.
[11]
Liu CXiao CJianjia Chen J,et al.Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma:a study of 966 patients[J]. BMC Cancer201919(1):622.
[12]
Kim SYKim BWPyo JY,et al. Macrometastasis in papillary thyroid cancer patients is associated with higher recurrence in lateral neck nodes[J].World J Surg201842(1):123-129.
[13]
常靖涛,王崴然,贾宝凇,等. cN0 多灶甲状腺微小乳头状癌与中央区淋巴结转移关系的研究进展[J]. 中国普外基础与临床杂志202128(3):382-388.
[14]
Yulian EDKurnia AKartini D,et al. Endoscopic thyroidectomy via axillary-breast-shoulder approach:Early experience of 42 cases[J]. Surg Oncol202034:318-323.
[15]
李勇杰,李斌,王艳普,等. 不同入路甲状腺切除术治疗分化型甲状腺癌效果比较[J]. 中国实用医刊202148(18):51-54.
[16]
Cidoncha EMPrats IMCortes JL,et al. Scarless neck thyroidectomy using bilateral axillo-breast approach:Initial impressions after introduction in a specialized unit and a review of the literature[J]. Cir Esp201997(2):81-88.
[17]
彭瑶,白宁,王文龙,等.全乳晕腔镜途径与传统开放手术治疗T1期乳头状甲状腺癌的疗效比较[J].中国普通外科杂志201827(5):535-540.
[18]
郑乐葳,袁芊芊,廖亦秦. 甲状腺术中神经监测联合“喉上神经外支分型”在喉上神经功能保护中的应用价值研究[J]. 中华耳鼻咽喉头颈外科杂志202156(10):1087-1092.
[19]
王俊潇,刘鄂长,伍晓兰. 甲状腺微小乳头状癌全乳晕腔镜手术与开放手术的疗效比较[J]. 腹腔镜外科杂志202126(8):612-617.
[1] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[2] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[3] 黄汇, 朱信强. 131I治疗45岁以下分化型甲状腺癌的疗效及影响因素[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 627-630.
[4] 樊丽超, 郭瑾瑛, 陈鑫. 野生型RET与RET/PTC融合基因检测对甲状腺乳头状癌中央区淋巴结清扫的指导意义[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 631-635.
[5] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[6] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[7] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[8] 徐成, 王璐璐, 王少华. 洗脱液甲状腺球蛋白在甲状腺乳头状癌转移淋巴结中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 701-704.
[9] 陈航, 闵翔. 日间甲状腺切除术后出血的12例临床分析及应对措施[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 600-602.
[10] 罗佳, 赵晶晶, 曹小珍, 钟玲, 范林军, 曾令娟. 单侧腋窝双侧乳晕入路机器人甲状腺术后局部加压预防皮下隧道出血的对照研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 603-606.
[11] 黄崇植, 肖映胜, 杨熙鸿, 林炘. 甲状腺下动脉的上行分支在甲状腺术中定位喉返神经的应用研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 607-610.
[12] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[13] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[14] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[15] 孙秀艳, 徐庆蕾, 马鹏涛, 胡志元, 郭传真, 祝成红. 腹腔镜胃癌根治术中患者体温变化与压力性损伤及受压部位微环境的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 480-484.
阅读次数
全文


摘要